New Agents in the Treatment of Psychiatric Disorders: What Innovations and in What Areas of Psychopathology?
Psychiatric disorders are a major cause of illness in the world. Unfortunately, many patients are resistant to treatment and present serious complications. Schizophrenia is refractory to treatment in about one-third of patients. Antidepressants are effective in about half of patients. Suicidal ideat...
Saved in:
| Main Authors: | Paola Bozzatello, Roberta Novelli, Rebecca Schisano, Claudio Brasso, Paola Rocca, Silvio Bellino |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/5/665 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lipidomics and genomics in mental health: insights into major depressive disorder, bipolar disorder, schizophrenia, and obsessive-compulsive disorder
by: Martina Nicole Modesti, et al.
Published: (2025-03-01) -
Somatic delusions and obsessive-compulsive disorder in schizophrenia
by: Arnold C. Lawrence, et al.
Published: (2010-12-01) -
Lamotrigine monotherapy for management of bipolar depression with comorbid obsessive-compulsive disorder in a second trimester anemic pregnant female
by: Anjali Sharma, et al.
Published: (2025-05-01) -
Prevalence of obsessive-compulsive symptoms in patients with schizophrenia treated with clozapine: a scoping review
by: Evelyn Moreno Tarazona, et al.
Published: (2025-01-01) -
Psychopathological Implications of Behavioral Patterns in Obsessive–Compulsive Rituals: A Hierarchical Analysis
by: Luca Gambolò, et al.
Published: (2025-05-01)